Fig. 2.
Plasma and cerebrospinal fluid (CSF) levels of leucine-rich alpha-2-glycoprotein 1 (LRG1) in study participants with subarachnoid hemorrhage (SAH) and controls. Plasma LRG1 levels are significantly (p < 0.001) higher in study participants with SAH compared with cardiac controls. CSF levels (log-normalized) of LRG1 levels are not significantly higher compared with those in TGN controls